Stocks-HIK.L-Hikma Pharmaceuticals PLC

HIK.L Hikma Pharmaceuticals PLC

0 0 (0%)
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Hikma Pharmaceuticals PLC's revenues increased by 10.08% and amounted to 2.04B. Net income decreased by 49.23% to 155.06M. Net assets decreased by 1.96% to 1.79B and EPS decreased from 1.31 to 0.68.
HIK.L's Investor Relations
Income StatementBalance SheetCash Flow Statement
Gross Margin
46.94%
Net Profit Margin
16.11%
Operating Margin
21.87%
Return On Investment
14.30%